Details of the Drug | DrugMAP

General Information of Drug (ID: DM6S9JP)

Drug Name

AZD4694

Indication

Disease Entry	ICD 11	Status	REF
Alzheimer disease	8A20	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Cross-matching ID

PubChem CID: 71306407
TTD ID: D08VDM

References

1	ClinicalTrials.gov (NCT00991419) To Compare Positron Emission Tomography (PET) Measurements of Fibrillar Amyloid Burden. U.S. National Institutes of Health.